.avif)
LDH Test - Kidney Cancer Biomarker
The LDH (lactate dehydrogenase) test measures an enzyme released when tissues are damaged, providing a quick signal of abnormal cell injury. Detecting elevated LDH early can prompt evaluation for liver disease, heart attack, hemolysis, muscle injury or certain cancers so you can get treatment sooner and reduce risk of complications.
VEGF Test - Kidney Cancer Biomarker
This VEGF test measures vascular endothelial growth factor to detect abnormal blood‑vessel growth linked to cancers, diabetic retinopathy, age‑related macular degeneration, preeclampsia, and some cardiovascular conditions. Early identification of abnormal VEGF levels can prompt timely monitoring or treatment, potentially helping you avoid vision loss, tumor progression, pregnancy complications, and other serious outcomes.
CAIX Test - Kidney Cancer Biomarker
The CAIX test measures Carbonic Anhydrase IX, a biomarker of tumor hypoxia used to detect and monitor certain cancers. By identifying elevated CAIX levels early, it can help guide treatment decisions and reduce the risk of delayed diagnosis and disease progression.
.svg)
